Ultragenyx Pharmaceutical Affirms FY2026 Sales Guidance of $730.000M-$760.000M vs $746.958M Est

Benzinga Newsdesk www.benzinga.com Negative 43.6%

Neg 43.6% Neu 0% Pos 0%

Comments

No comments yet. Be the first!